Isoflurane Postconditioning Inhibits tPA-Induced Matrix Metalloproteinases Activation After Hypoxic Injury via Low-Density Lipoprotein Receptor-Related Protein and Extracellular Signal-Regulated Kinase Pathway

Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia–reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway

(2016) Sheng Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

Immortalized endothelial cell lines for in vitro blood–brain barrier models: A systematic review

(2016) Nurul Adhwa Rahman et al.   BRAIN RESEARCH

Recombinant tissue plasminogen activator promotes, and progesterone attenuates, microglia/macrophage M1 polarization and recruitment of microglia after MCAO stroke in rats

(2015) Soonmi Won et al.   BRAIN BEHAVIOR AND IMMUNITY

The effect of recombinant tissue plasminogen activator on MMP-2 and MMP-9 activitiesin vitro

(2014) Piotr Golab et al.   NEUROLOGICAL RESEARCH

Isoflurane postconditioning improved long-term neurological outcome possibly via inhibiting the mitochondrial permeability transition pore in neonatal rats after brain hypoxia–ischemia

(2014) P. Zhao et al.   NEUROSCIENCE

Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke

(2013) Joyce S. Balami et al.   CNS & Neurological Disorders-Drug Targets

The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke

(2013) Jacek Kurzepa et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Progesterone Attenuates Hemorrhagic Transformation after Delayed tPA Treatment in an Experimental Model of Stroke in Rats: Involvement of the VEGF–MMP Pathway

(2013) Soonmi Won et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Isoflurane postconditioning reduces ischemia-induced nuclear factor-κB activation and interleukin 1β production to provide neuroprotection in rats and mice

(2013) Hong Li et al.   NEUROBIOLOGY OF DISEASE

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

(2013) Edward C. Jauch et al.   STROKE

Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke

(2013) Shaheen E. Lakhan et al.   Frontiers in Neurology

Intracellular Signaling MAPK Pathway After Cerebral Ischemia–Reperfusion Injury

(2012) Maria Kovalska et al.   NEUROCHEMICAL RESEARCH

Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3β in human neuron-like cells

(2011) D. Lin et al.   NEUROSCIENCE

Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease

(2011) Yi Yang et al.   STROKE

Responsive nematic gels from the self-assembly of aqueous nanofibres

(2011) Zhegang Huang et al.   Nature Communications

The Contribution of L-Arginine to the Neurotoxicity of Recombinant Tissue Plasminogen Activator following Cerebral Ischemia: A Review of rtPA Neurotoxicity

(2010) George WJ Harston et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Isoflurane Posttreatment Reduces Neonatal Hypoxic–Ischemic Brain Injury in Rats by the Sphingosine-1-Phosphate/Phosphatidylinositol-3-Kinase/Akt Pathway

(2010) Yilin Zhou et al.   STROKE

Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein

(2009) Y. Suzuki et al.   BLOOD

Microglial Low-Density Lipoprotein Receptor-Related Protein 1 Mediates the Effect of Tissue-Type Plasminogen Activator on Matrix Metalloproteinase-9 Activity in the Ischemic Brain

(2009) Chen Zhang et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk

(2009) Quan-Guang Zhang et al.   NEUROSCIENCE RESEARCH

Isoflurane preconditioning activates HIF-1α, iNOS and Erk1/2 and protects against oxygen–glucose deprivation neuronal injury

(2008) Qi-fang Li et al.   BRAIN RESEARCH

Nuclear Factor- B Induction by Visfatin in Human Vascular Endothelial Cells: Its role in MMP-2/9 production and activation

(2008) R. Adya et al.   DIABETES CARE